Cardiometabolic risk profiles in subclinical hypothyroidism, and the potential impact of statin therapy: A cross-sectional and longitudinal study
SH is linked to a more adverse cardiovascular, metabolic and hepatic profile, indicating its potential as a candidate risk modifier. Intensive risk factor management is warranted, along with L-thyroxine supplementation in selected cases.
Authors
- Μaria Dalamaga (ORCID: https://orcid.org/0000-0002-7008-388X)
- Natalia G. Vallianou (ORCID: https://orcid.org/0000-0003-3874-5393)
- Ιrene Karampela (ORCID: https://orcid.org/0000-0001-6912-4042)
- Dimitrios Tsilingiris (ORCID: https://orcid.org/0000-0002-6864-4289)
- Theodora Stratigou (ORCID: https://orcid.org/0000-0003-3186-7099)
- Dimitrios Kounatidis
Institutions
- Democritus University of Thrace (GR)
- National and Kapodistrian University of Athens (GR)
- Sismanoglio General Hospital (GR)
- Laiko General Hospital of Athens (GR)
- University Hospital of Alexandroupolis (GR)
- Evangelismos Hospital (GR)
Publication Details
- Journal
- Metabolism Open
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1016/j.metop.2025.100394
- Citations
- 3
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 3.88